Background
Human cryptosporidiosis is caused by infection with the Apicomplexa protozoans of the genus Cryptosporidium. Human illness was formerly thought to be caused by a single species, but molecular studies have demonstrated that several different species cause human cryptosporidiosis. Among the more common species are Cryptosporidium hominis, for which humans are the only natural host, and Cryptosporidium parvum, which infects bovines as well as humans.[1, 2] (See Etiology.)
Cryptosporidiosis mainly affects children. It causes a self-limited diarrheal illness in healthy individuals. Cryptosporidiosis is also recognized as a cause of persistent diarrhea in children and of severe, prolonged diarrhea in persons with acquired immunodeficiency syndrome (AIDS). The source of most endemic cryptosporidiosis cases is human-to-human fecal-oral transmission, but infection may also result from animal-to-person transmission and waterborne transmission. Major outbreaks resulting from waterborne transmission have been recorded.[3] (See Etiology, Epidemiology.)
Outbreaks of cryptosporidiosis should be detected by vigilant observation for increased case numbers at primary and public health care levels. (See Epidemiology.)
Also see Pediatric Cryptosporidiosis.
Etiology
Cryptosporidium oocysts are highly infectious, requiring only 101 to 103 oocysts to cause human disease (50% infectious dose, 102). The oocysts are infectious immediately after excretion, and the life cycle of the parasite produces forms that reinvade the intestine. The location of the parasite in the intestine is intracellular but extracytoplasmic, which may contribute to the marked resistance of Cryptosporidium species to treatment. Large numbers of oocysts are excreted and are resistant to harsh conditions, including chlorine at levels usually applied in water treatment.
The mechanism by which Cryptosporidium causes diarrhea includes a combination of increased intestinal permeability, chloride secretion, and malabsorption, which are all thought to be caused by the host response to infection. In immunocompetent persons, the infection is usually limited to the small intestine. In persons with AIDS or certain congenital immunodeficiencies, the biliary tract may be involved.
Epidemiology
Incidence in the United States
The frequency of cryptosporidiosis has not been well-defined. About 30% of the adult population of the United States is seropositive. The number of cases diagnosed has increased with improved diagnostic testing, with over 10,500 cases reported in 2008.[4] Still, most laboratories do not routinely test for this organism, and many laboratories use insensitive tests when testing for Cryptosporidium.[1] Studies have documented cryptosporidiosis in about 4% of stools sent for parasitologic examination.[5] More recently in studies using polymerase chain reaction (PCR) tests, Cryptosporidium species have been diagnosed in 6% of American travelers to Mexico.[6]
Prior to the availability of combination antiretroviral therapy, approximately 10-15% of patients with AIDS developed cryptosporidiosis over their lifetime. Like other opportunistic infections, the prevalence of cryptosporidiosis in AIDS patients has dropped dramatically.
International incidence
In developing countries, most people are infected as children. For example, studies in Brazil documented an infection rate of 90% for children under age 5 years who were living in slums. Serologic and stool studies have documented high rates of infection in Latin America, Africa, the Middle East, and South Asia. Overall, about 13% of stool studies submitted for parasitologic studies in developing countries reveal Cryptosporidium oocysts.
In persons with AIDS, the rate of cryptosporidiosis is higher in developing countries, ranging from 12-48% of persons with AIDS who have diarrhea.[1, 7]
Age predilection
The peak incidence of cryptosporidiosis is in children younger than 5 years. Infection is rare in immunocompetent adults in developing countries but can occur in persons with AIDS.
Prognosis
Prolonged diarrhea (ie, >1 mo) and biliary disease indicate a poor prognosis in persons with AIDS.
Complications
Sclerosing cholangitis, acalculous cholecystis, papillary stenosis, and pancreatitis may develop with biliary involvement.
Patients with AIDS may develop respiratory tract infections.
Rare cases of pancreatitis have been recorded in immunocompetent patients.
Cryptosporidiosis is an important cause of persistent diarrhea in developing countries. Children with persistent diarrhea develop worsening malnutrition, which may result in cognitive and fitness problems that persist for years.[8]
Chronic cryptosporidiosis may be complicated by biliary tract disease, malabsorption, and death in individuals with AIDS and malnourished children.[9]
Patient Education
Encourage immunocompromised patients to consider using 1-μm water filters when drinking tap water.
Instruct patients to boil or filter water in countries with a high risk of transmission.
Instruct immunocompromised patients to avoid newborn animals (eg, calves, lambs), including domestic animals, and people with diarrhea. New pets for patients with AIDS should be older than 6 months and should not have diarrhea.
Instruct patients with AIDS, daycare workers, food handlers, and healthcare workers to avoid fecal-oral spread by wearing gloves and washing their hands after contact with human feces. Spread can occur after activities such as changing diapers.
White AC Jr. Cryptosporidiosis (Cryptosporidium hominis, Cryptosporidium parvum, other species). In: Mandell GL, Bennett JE, Dolin R, ed. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:3215-3228.
Lima AAM, Samie A, Guerrant RL. Cryptosporidiosis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases. Philadelphia, Pa: Elsevier-Churchill Livingstone; 2011:640-63.
Yoder JS, Beach MJ. Cryptosporidium surveillance and risk factors in the United States. Exp Parasitol. Jan 2010;124(1):31-9. [Medline].
Yoder JS, Harral C, Beach MJ. Cryptosporidiosis surveillance - United States, 2006-2008. MMWR Surveill Summ. Jun 11 2010;59(6):1-14. [Medline].
Amin OM. Seasonal prevalence of intestinal parasites in the United States during 2000. Am J Trop Med Hyg. Jun 2002;66(6):799-803. [Medline].
Nair P, Mohamed JA, DuPont HL, et al. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg. Aug 2008;79(2):210-4. [Medline]. [Full Text].
Wumba R, Longo-Mbenza B, Mandina M, et al. Intestinal parasites infections in hospitalized AIDS patients in Kinshasa, Democratic Republic of Congo. Parasite. Dec 2010;17(4):321-8. [Medline].
Mondal D, Haque R, Sack RB, Kirkpatrick BD, Petri WA Jr. Attribution of malnutrition to cause-specific diarrheal illness: evidence from a prospective study of preschool children in Mirpur, Dhaka, Bangladesh. Am J Trop Med Hyg. May 2009;80(5):824-6. [Medline].
Opintan JA, Newman MJ, Ayeh-Kumi PF, et al. Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg. Oct 2010;83(4):936-43. [Medline]. [Full Text].
O'connor RM, Shaffie R, Kang G, Ward HD. Cryptosporidiosis in patients with HIV/AIDS. AIDS. Mar 13 2011;25(5):549-60. [Medline].
Kaushik K, Khurana S, Wanchu A, Malla N. Evaluation of staining techniques, antigen detection and nested PCR for the diagnosis of cryptosporidiosis in HIV seropositive and seronegative patients. Acta Trop. Jul 2008;107(1):1-7. [Medline].
Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. Nov 2 2002;360(9343):1375-80. [Medline].
Rossignol JF, Kabil SM, el-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol. Mar 2006;4(3):320-4. [Medline].
Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. Jul 1 2001;184(1):103-6. [Medline].
Kotler DP, Fogleman L, Tierney AR. Comparison of total parenteral nutrition and an oral, semielemental diet on body composition, physical function, and nutrition-related costs in patients with malabsorption due to acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr. May-Jun 1998;22(3):120-6. [Medline].
Lee MB, Greig JD. A review of gastrointestinal outbreaks in schools: effective infection control interventions. J Sch Health. Dec 2010;80(12):588-98. [Medline].
Cabada MM, White AC Jr. Treatment of cryptosporidiosis: do we know what we think we know?. Curr Opin Infect Dis. Oct 2010;23(5):494-9. [Medline].
Pantenburg B, White AC Jr. Nitazoxanide. In: Grayson ML, ed. Kucer's The Use of Antibiotics. 6th ed. London, United Kingdom: Hodder Arnold; 2010:2132-9.

